Glen Allen, VA, October 23, 2024 - PRISM MediaWire - Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other...
NEWSROOM
Stock Market
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024
MIAMI, FL., October 23, 2024 – PRISM MediaWire - NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, (“NRx,” the “Company”) and HOPE Therapeutics, Inc., a medical and technology driven company and wholly-owned subsidiary of NRx, today announced they will be featured as a participating in the ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate...
Siyata Mobile to Present at The ThinkEquity Conference
Presentation on October 30 at 4 p.m. ET, and Attend 1x1 Meetings Vancouver, BC, October 23, 2024 - PRISM MediaWire - Siyata Mobile Inc. (Nasdaq: SYTA/SYTAW) (“Siyata” or the “Company”), a global vendor of Push-to-Talk over Cellular (“PoC”) devices and cellular signal booster systems, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate...
Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor
Discoverer of Klotho gene further strengths KLTO Scientific Advisory Board New York, NY, October 23, 2024 - PRISM MediaWire - Klotho Neurosciences, Inc. (NASDAQ: KLTO), a leading biotechnology company focused on developing cell and gene therapies for aging and age-related diseases, is proud to announce the appointment of Dr. Makoto Kuro-o to its Scientific Advisory Board. Dr. Kuro-o, a distinguished Japanese physician-scientist, is widely recognized as the pioneer behind the discovery of the...
SPZI: JP3E and China Petroleum Technology and Development Corporation, China’s Largest International Trading Company, Announce Partnership
Jointly Initiating First Coal Shipment Utilizing Bloxcross’ Proprietary Trade Finance Platform NEW YORK, October 22, 2024 - PRISM MediaWire - JP 3E Holdings, Inc. (OTC: SPZI), through its wholly-owned subsidiary JP Energy Global PTE, LTD, announces a major strategic partnership with China Petroleum Technology and Development Corporation (CPTDC), China's largest international trading company. This partnership marks a significant milestone with the first coal shipment initiated under the...
AmpliTech Group’s AGTGSS Division Signs 5 Year Supplier Agreement With Fujitsu Spain For Private 5G Network Products
Hauppauge, NY, October 22, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced the signing of a 5 Year Supplier Agreement to provide Fujitsu with a varied array of Private 5G...
PRISM MarketView Joins ThinkEquity Conference as Official Media Sponsor
NEW YORK, October 21, 2024 – PRISM MediaWire - PRISM MarketView is proud to announce its role as the official media sponsor for the upcoming ThinkEquity Conference, a premier event bringing together investors, innovators, and industry leaders. The conference will be held at the Mandarin Oriental New York on Oct. 30, offering an exceptional platform for companies and investors to connect, collaborate and explore emerging opportunities. The ThinkEquity Conference is hosted by ThinkEquity, a...
Innocan Pharma to Present at the 2024 ThinkEquity Conference
Herzliya, Israel and Calgary, Alberta, October 21, 2024 - PRISM MediaWire - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in chronic pain management via Liposomal CBD drug products, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry...
Nova Minerals to Highlight Estelle Project Advancements at 2024 ThinkEquity Conference
Management to Present at 8.30-9.00 AM on Wednesday, October 30, 2024, in South Salon I Estelle Project Positioned as a World-Class Gold and Antimony Asset with Multi-Million Ounce Resources Anchorage, Alaska, Oct. 21, 2024 - PRISM MediaWire - Nova Minerals Limited (“Nova” or the “Company”) (NASDAQ: NVA) (ASX: NVA) (FRA: QM3), a gold, antimony and critical minerals exploration and development company focused on advancing the Estelle Project in Alaska, will present its latest drill results and...
StemSation International Announces Execution of a Letter of Intent (LOI) to Acquire Gorilla Marketing Group, LLC
StemSation International announced today the execution of a Letter of Intent outlining the terms for the acquisition of the private marketing company, Gorilla Marketing Group, LLC Plantation, Florida, October 21, 2024 - PRISM MediaWire - StemSation International (OTC: STSN), a South-Florida based company that has licensed technology for the production and distribution of flavored, canned oxygen products is announcing the execution of a Letter of Intent that outlines the terms and milestone...
Pyxis Tankers to Present at the 2024 ThinkEquity Conference
Maroussi, Greece, October 21, 2024 - PRISM MediaWire - Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), (“we”, “our”, “us”, the “Company” or “Pyxis Tankers”), an international shipping company, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients and other industry professionals to highlight groundbreaking innovations and financial...
American Shared Hospital Services Announces Key Management Appointments
Hires Gary Delanois, Seasoned Radiation Oncology Services Executive, as Chief Operating Officer Promotes Ranjit Pradhan to Senior Vice President of Sales and Marketing SAN FRANCISCO, CA, October 18, 2024 - PRISM MediaWire - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced the appointment of Gary Delanois as...
Roadzen to Present at the ThinkEquity Investor Conference October 30, 2024
NEW YORK, October 18, 2024 - PRISM MediaWire - Roadzen Inc. (Nasdaq: RDZN) ("Roadzen" or the "Company”), a global leader in AI at the convergence of insurance and mobility, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies. Rohan...
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
NEWTOWN, Pa., Oct. 18, 2024 - PRISM MediaWire - Helius Medical Technologies, Inc. (“Helius” or the “Company”) [Nasdaq: HSDT], a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that it plans to participate in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals...
Universal Media Group, Inc.’s award-winning TV show Before The Fame with Mike Sherman has been nominated for a Suncoast Emmy for the third consecutive year
Miami, FL., October 17th, 2024 - PRISM MediaWire - Universal Media Group, Inc. (OTC: UMGP), headquartered in Boca Raton, Florida, is the production company behind the Emmy-nominated television show Before The Fame with Mike Sherman. The show has just earned its third consecutive nomination from the Suncoast Emmy committee, this time for a special episode featuring music superstar Shaggy. In this episode, Shaggy sits down with Mike Sherman to discuss his remarkable journey, from serving in the...
BioStem Technologies Reports Breakthrough Results in a Diabetic Foot Ulcer Wound Closure Study Comparing BioREtain® to Standard of Care Treatment
Retrospective Study demonstrates clinical efficacy and statistical support for tissue processed via BioREtain to care for treatment-resistant chronic wounds Study published in the peer-reviewed journal, ‘International Wound Journal’ POMPANO BEACH, Fla., Oct. 17, 2024 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived biologics for advanced wound care, announces breakthrough...
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
IRVINE, Calif., Oct. 16, 2024 - PRISM MediaWire - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, announced today that CEO Josh Riggs is scheduled to present at the 17th annual Main Event, hosted by LD Micro, on Tuesday, October 29th in Los Angeles. Oncocyte management will also be available for one-on-one meetings with investors. To schedule a one-on-one meeting, please contact Julie Silber at PCG Advisory (jsilber@pcgadvisory.com) or request a meeting via the LD Micro...
SKYX Announces a Collaboration with Wayfair for its Advanced and Smart Plug & Play Lighting for Retail and Professional Segments including Designers and Architects
SKYX will Offer a Variety of its Advanced and Smart Plug & Play Lighting and Ceiling Fan Products, Plug & Play Retrofit Kits and Recessed Lights, Ceiling Outlet Receptacles, and More Miami, FL. October 16, 2024 – PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, with a mission to make homes and buildings become smart, safe, and...
BioStem Technologies Establishes National Pricing for Vendaje AC® from the Center for Medicare Services and Provides Reimbursement in All MAC Regions
Vendaje AC to launch across MAC regions nationwide through Venture Medical, the Company’s exclusive sales and marketing partner for AmnioWrap2® POMPANO BEACH, Fla., Oct. 15, 2024 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announced that the Center for Medicare Services (CMS) has established national pricing for its allograft...
Sono-Tek Reports Fiscal Second Quarter and First Half 2025 Financial Results, Record Backlog and Provides Revenue Guidance
Q2 Sequential Revenue Growth Meets Quarterly Guidance of 2%-5% Record Equipment and Service Backlog of $11.7 Million First Half Revenue Growth of 10% YOY, First Half Net Income Growth of 13% YOY Expects Continued Revenue Growth for Full Fiscal Year 2025 Conference Call Today at 10:00 am ET MILTON, N.Y., October 15, 2024 – PRISM MediaWire - Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for the second...
Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences
KLTO strengthens team with industry veteran and is poised to accelerate the development of its therapeutic candidates New York, NY, October 15, 2024 - PRISM MediaWire - Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies for aging and age-related diseases, today announced the appointment of Peter Moriarty, Co-Founder of Shire Pharmaceuticals, as its Chief Operating Officer (COO). “We are thrilled to have Peter join Klotho...
Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform
Patent application covers key technology innovations for delivering therapeutic agents Proprietary technology enables precise delivery to improve safety and efficacy in oncology, cancer survivorship and immunotherapy Allowance provides broad IP protection for drug-delivery platform and extends market exclusivity for two lead clinical assets currently in Phase 2 trials PITTSBURGH, PA, October 15, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage...
SPZI: JP 3E Holdings, Inc. Accelerates Growth with Major Corporate Milestones Toward Uplisting
NEW YORK, October 14, 2024 – PRISM MediaWire - JP 3E Holdings, Inc. (OTC: SPZI), formerly Spooz, Inc., is excited to announce a series of significant corporate developments that mark a new era of growth and expansion for the company. These strategic initiatives include steps to uplist to the OTCQB market, filing a Form 10, following which, it will initiate 15c2-11 filing, become a fully reporting company under SEC guidelines, remove the "shell risk" designation, and implement a comprehensive...
In Light of World Mental Health Day, PRISM Highlights Mental Health Index Companies Making a Difference
New York, New York, October 10, 2024 - PRISM MediaWire - PRISM MediaWire - Mental health has not always been a topic to discuss as easily as other health related topics due to the stigma surrounding it. Those who have identified having a mental health condition typically do not seek the proper help or treatment for fear of judgement or admission to being unstable. The reality of it is that whether or not you have a condition, we all need to do things to ensure we have good mental health in the...
Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit
PITTSBURGH, Oct. 09, 2024 - PRISM MediaWire - Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced that CEO Jonathan Kaufman, PhD will be presenting at the 2024 Maxim Healthcare Virtual Summit that is being held on October 15 -17, 2024. Event: Lipella Presentation - 2024 Maxim Healthcare Virtual Summit Date: Thursday, October 17th, 2024...
SKYX Provides Corporate Update, including Significant Insider Buying
MIAMI, Oct. 09, 2024 - PRISM MediaWire - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and which owns over 60 lighting and home décor websites with a mission to make homes and buildings become smart, safe, and advanced as the new standard, provides today a corporate update including significant insider buying. SKYX Secures $11 million equity preferred stock investment...
Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial
Results published in peer-reviewed journal, Clinical Cancer Research Study validates DetermaIO’s utility in identifying breast cancer patients most likely to benefit from atezolizumab DetermaIO targets a multi-billion-dollar addressable market in oncology diagnostics IRVINE, Calif., October 8, 2024 - PRISM MediaWire - Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, announced the peer-reviewed publication of positive data related to its proprietary gene expression test,...
Sono-Tek Announces Fiscal Second Quarter and First Half 2025 Earnings Conference Call
Conference Call on Tuesday, October 15, 2024 at 10:00 am ET MILTON, NY, October 8, 2024 – PRISM MediaWire - Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that the Company will hold a conference call to discuss its fiscal second quarter and first half 2025 financial results, ended August 31, 2024, on Tuesday, October 15, 2024 at 10:00 am ET. The second quarter and first half FY 2025 financial results press release will...
SKYX Secures $11 Million Strategic Investment at $2.00 Per Share, Preferred Stock Convertible, Led by Global Marriott Hotel-Chain Developer, Lance Shaner, Owner of over 60 Hotels, Primarily Marriotts
Management Emphasizes That It Has Sufficient Cash to Achieve Its Goals Including Recently Announced Collaborations and Being Cash Flow Positive During 2025 The $11 Million Investment includes Leading Builders and Hotel Developers MIAMI, October 07, 2024 - PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the "Company" or "SKYX"), a highly disruptive smart platform technology company with more than 97 issued and pending patents globally and over 60 lighting and...
AmpliTech Group Announces Receipt of Notice of Allowance for Patents in 5G and Cryogenic Technology For Quantum Computing Applications
Hauppauge, NY, October 7, 2024 – PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a Notice of...